CLINICAL_TRIALS
trial_result
· 2025-10-08
Clinical Trial Update: A Study of Lorcaserin as Adjunctive Treatment in Participants With Dravet Syndrome [Phase 3]
Summary
Phase 3 study of lorcaserin as an adjunctive treatment for Dravet syndrome was terminated; results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Eisai Inc. | Conditions: Epilepsies, Myoclonic | Phase 3 | Status: TERMINATED | Results posted: 2025-10-08